.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Queensland Health
Harvard Business School
QuintilesIMS
Argus Health
McKinsey
Healthtrust
Julphar
Chinese Patent Office
Boehringer Ingelheim

Generated: February 18, 2018

DrugPatentWatch Database Preview

Drug Master Files for: Taro Pharm

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
4623III6/10/1982TARO PHARMACEUTICALS INCFACIL & GEN OPER PROCEDS AT DOWNSVIEW, ONTARIO, CANADA LOCATION
4929AII3/17/1983TARO PHARMACEUTICAL INDUSTRIES LTDCARBAMAZEPINE USP
11018III8/4/1994TARO PHARMACEUTICAL INDUSTRIES LTDDESOXIMETASONE
12746AII11/18/1997TARO PHARMACEUTICAL INDUSTRIES LTDWARFARIN SODIUM CLATHRATE USP
13021AII6/15/1998TARO PHARMACEUTICAL INDUSTRIES LTDCLOMIPRAMINE HYDROCHLORIDE USP
13861AII11/25/1998TARO PHARMACEUTICAL INDUSTRIES LTDDESOXIMETASONE USP
13921AII12/30/1998TARO PHARMACEUTICAL INDUSTRIES LTDHYDROCORTISONE 17-VALERATE, USP
14151AII5/14/1999TARO PHARMACEUTICAL INDUSTRIES LTDFLUOCINONIDE USP MICRONIZED
14169AII6/2/1999TARO PHARMACEUTICAL INDUSTRIES LTDCLORAZEPATE DIPOTASSIUM USP
14374AII8/30/1999TARO PHARMACEUTICAL INDUSTRIES LTDAMCINONIDE USP MICRONIZED
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Citi
Boehringer Ingelheim
Express Scripts
Chinese Patent Office
Accenture
UBS
Deloitte
Healthtrust
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot